#researchupdates — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #researchupdates, aggregated by home.social.
-
· New study linked ongoing endothelial dysfunction in people with #LongCOVID with neuropsychiatric symptoms
[https://www.sciencedirect.com/science/article/pii/S2666354626000803?via%3Dihub#sec11]
· Small observational study from Jamaica found nearly half of pediatric participants met the diagnostic criteria for Long COVID
[https://journals.lww.com/pidj/fulltext/9900/long_covid_19_in_hospitalized_and_ambulatory.1720.aspx]
· Long COVID clinical trial investigating the cancer drug (sirolimus) rapamycin was recently updated to have an open label extension
[https://www.als-mnd.org/support-for-pals-cals/research/open-label-extension/]https://thesicktimes.org/2026/05/12/research-updates-may-12/
-
· A specific formula of probiotics was found to improve fatigue and other symptoms in people with #LongCOVID
[https://aga-fileuploader-bucket.s3.us-east-2.amazonaws.com/389%20Probiotics%20and%20Long%20COVID%20FNL.pdf]
· A new review on Long COVID concluded that addressing the heterogeneity of the disease is crucial for the future development of treatments
[https://www.nature.com/articles/s43856-025-01300-z]
· Another review in Frontiers evaluated PEM
[https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1774310/full] -
· A specific formula of probiotics was found to improve fatigue and other symptoms in people with #LongCOVID
[https://aga-fileuploader-bucket.s3.us-east-2.amazonaws.com/389%20Probiotics%20and%20Long%20COVID%20FNL.pdf]
· A new review on Long COVID concluded that addressing the heterogeneity of the disease is crucial for the future development of treatments
[https://www.nature.com/articles/s43856-025-01300-z]
· Another review in Frontiers evaluated PEM
[https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1774310/full] -
· A specific formula of probiotics was found to improve fatigue and other symptoms in people with #LongCOVID
[https://aga-fileuploader-bucket.s3.us-east-2.amazonaws.com/389%20Probiotics%20and%20Long%20COVID%20FNL.pdf]
· A new review on Long COVID concluded that addressing the heterogeneity of the disease is crucial for the future development of treatments
[https://www.nature.com/articles/s43856-025-01300-z]
· Another review in Frontiers evaluated PEM
[https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1774310/full] -
· A specific formula of probiotics was found to improve fatigue and other symptoms in people with #LongCOVID
[https://aga-fileuploader-bucket.s3.us-east-2.amazonaws.com/389%20Probiotics%20and%20Long%20COVID%20FNL.pdf]
· A new review on Long COVID concluded that addressing the heterogeneity of the disease is crucial for the future development of treatments
[https://www.nature.com/articles/s43856-025-01300-z]
· Another review in Frontiers evaluated PEM
[https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1774310/full] -
· A specific formula of probiotics was found to improve fatigue and other symptoms in people with #LongCOVID
[https://aga-fileuploader-bucket.s3.us-east-2.amazonaws.com/389%20Probiotics%20and%20Long%20COVID%20FNL.pdf]
· A new review on Long COVID concluded that addressing the heterogeneity of the disease is crucial for the future development of treatments
[https://www.nature.com/articles/s43856-025-01300-z]
· Another review in Frontiers evaluated PEM
[https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1774310/full] -
· A clinical trial for non-invasive vagal nerve stimulation failed in improving fatigue in #LongCOVID
· A new study in JACC Advances compared two common types of dysautonomia in Long COVID, as well as their overlap
· German health insurance companies will cover four off-label drugs for Long COVID and related diseaseshttps://thesicktimes.org/2026/04/07/research-updates-april-7/
-
· A clinical trial for non-invasive vagal nerve stimulation failed in improving fatigue in #LongCOVID
· A new study in JACC Advances compared two common types of dysautonomia in Long COVID, as well as their overlap
· German health insurance companies will cover four off-label drugs for Long COVID and related diseaseshttps://thesicktimes.org/2026/04/07/research-updates-april-7/
-
· A clinical trial for non-invasive vagal nerve stimulation failed in improving fatigue in #LongCOVID
· A new study in JACC Advances compared two common types of dysautonomia in Long COVID, as well as their overlap
· German health insurance companies will cover four off-label drugs for Long COVID and related diseaseshttps://thesicktimes.org/2026/04/07/research-updates-april-7/
-
· A clinical trial for non-invasive vagal nerve stimulation failed in improving fatigue in #LongCOVID
· A new study in JACC Advances compared two common types of dysautonomia in Long COVID, as well as their overlap
· German health insurance companies will cover four off-label drugs for Long COVID and related diseaseshttps://thesicktimes.org/2026/04/07/research-updates-april-7/
-
· A clinical trial for non-invasive vagal nerve stimulation failed in improving fatigue in #LongCOVID
· A new study in JACC Advances compared two common types of dysautonomia in Long COVID, as well as their overlap
· German health insurance companies will cover four off-label drugs for Long COVID and related diseaseshttps://thesicktimes.org/2026/04/07/research-updates-april-7/
-
CERN releases report on the feasibility of a possible Future Circular Collider
#HackerNews #CERN #FutureCircularCollider #ParticlePhysics #ScienceInnovation #ResearchUpdates
-
· People with recent COVID-19 at higher risk for other viral and bacterial infections
· A 15-day course of #Paxlovid did not “significantly improve health outcomes in participants with #LongCOVID
· 2. study showed that Paxlovid taken within 5 days of infection with COVID-19 did help with the acute phase of COVID-19 in children
· Rapamycin, a drug used for organ transplants, may help alleviate symptoms of myalgic encephalomyelitis #MECFShttps://thesicktimes.org/2025/04/08/research-updates-april-8/
-
The Continuing Crisis, Part IX: Inside the NIH Now
https://www.science.org/content/blog-post/continuing-crisis-part-ix-inside-nih-now
#HackerNews #ContinuingCrisis #NIH #ScienceBlog #ResearchUpdates #HealthPolicy
-
To achieve this, we developed #DynamiR (https://codeberg.org/a_probst/DynamiR).
DynamiR a Python-based open-source tool with minimal dependencies, making it easy for anyone to analyze independently.
It's built on open data and decentralized, ensuring flexibility and adaptability.
#miRNA #NeurodegenerativeDiseases #ResearchUpdates #OpenScience #SoftwareDevelopment #PD #ALS #HD
-
To achieve this, we developed #DynamiR (https://codeberg.org/a_probst/DynamiR).
DynamiR a Python-based open-source tool with minimal dependencies, making it easy for anyone to analyze independently.
It's built on open data and decentralized, ensuring flexibility and adaptability.
#miRNA #NeurodegenerativeDiseases #ResearchUpdates #OpenScience #SoftwareDevelopment #PD #ALS #HD
-
To achieve this, we developed #DynamiR (https://codeberg.org/a_probst/DynamiR).
DynamiR a Python-based open-source tool with minimal dependencies, making it easy for anyone to analyze independently.
It's built on open data and decentralized, ensuring flexibility and adaptability.
#miRNA #NeurodegenerativeDiseases #ResearchUpdates #OpenScience #SoftwareDevelopment #PD #ALS #HD